Clinical Trials Logo

Cutibacterium Acnes clinical trials

View clinical trials related to Cutibacterium Acnes.

Filter by:
  • None
  • Page 1

NCT ID: NCT05919888 Completed - Surgery Clinical Trials

SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty

Start date: June 26, 2023
Phase: Phase 4
Study type: Interventional

Comparing the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus antimicrobial wound gel versus betadine applied to the skin layer after the skin incision has been made. Reducing the bacteria present in the deep tissues at the end of the surgery may prevent infections from developing in the future.

NCT ID: NCT03950063 Not yet recruiting - Cutibacterium Acnes Clinical Trials

Cutibacterium Acnes in Bone and Joint Infections

CaBJI
Start date: June 15, 2019
Phase:
Study type: Observational

Prosthetic Joint Infections (PJIs) are increasing with the use of orthopedic devices on an ageing population. Cutibacterium acnes is a commensal organism that plays an important role in the ecosystem healthy human skin, yet this species is also recognized as a pathogen in foreign body infection: endocarditis, prostatitis and specifically in PJIs. C. acnes is able to escape the immune system. This phenomenon could reflect two bacterial behavior: the bacterial internalization by host cells and the biofilm formation.